Literature DB >> 20027484

Differential binding with ERalpha and ERbeta of the phytoestrogen-rich plant Pueraria mirifica.

C Boonchird1, T Mahapanichkul, W Cherdshewasart.   

Abstract

Variations in the estrogenic activity of the phytoestrogen-rich plant, Pueraria mirifica, were determined with yeast estrogen screen (YES) consisting of human estrogen receptors (hER) hERalpha and hERbeta and human transcriptional intermediary factor 2 (hTIF2) or human steroid receptor coactivator 1 (hSRC1), respectively, together with the beta-galactosidase expression cassette. Relative estrogenic potency was expressed by determining the beta-galactosidase activity (EC(50)) of the tuber extracts in relation to 17beta-estradiol. Twenty-four and 22 of the plant tuber ethanolic extracts interacted with hERalpha and hERbeta, respectively, with a higher relative estrogenic potency with hERbeta than with hERalpha. Antiestrogenic activity of the plant extracts was also determined by incubation of plant extracts with 17beta-estradiol prior to YES assay. The plant extracts tested exhibited antiestrogenic activity. Both the estrogenic and the antiestrogenic activity of the tuber extracts were metabolically activated with the rat liver S9-fraction prior to the assay indicating the positive influence of liver enzymes. Correlation analysis between estrogenic potency and the five major isoflavonoid contents within the previously HPLC-analyzed tuberous samples namely puerarin, daidzin, genistin, daidzein, and genistein revealed a negative result.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20027484     DOI: 10.1590/s0100-879x2009007500026

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  9 in total

1.  Development of a simple and rapid method for the detection of isomiroestrol in Pueraria candollei by an immunochromatographic strip test.

Authors:  Jiranan Chaingam; Tharita Kitisripanya; Supaluk Krittanai; Seiichi Sakamoto; Hiroyuki Tanaka; Waraporn Putalun
Journal:  J Nat Med       Date:  2019-04-11       Impact factor: 2.343

Review 2.  Medical applications of phytoestrogens from the Thai herb Pueraria mirifica.

Authors:  Suchinda Malaivijitnond
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 3.  Botanical modulation of menopausal symptoms: mechanisms of action?

Authors:  Atieh Hajirahimkhan; Birgit M Dietz; Judy L Bolton
Journal:  Planta Med       Date:  2013-02-13       Impact factor: 3.352

4.  Simple, sensitive and reliable in vivo assays to evaluate the estrogenic activity of endocrine disruptors.

Authors:  Kanya Anukulthanakorn; Sukanya Jareonporn; Suchinda Malaivijitnond
Journal:  Reprod Med Biol       Date:  2013-07-18

5.  Puerarin suppresses invasion and vascularization of endometriosis tissue stimulated by 17β-estradiol.

Authors:  Dan Wang; Yuhuan Liu; Jie Han; Dongxia Zai; Mei Ji; Wen Cheng; Ling Xu; Luxi Yang; Miaoxia He; Jian Ni; Zailong Cai; Chaoqin Yu
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

6.  Effects of total flavonoids from Drynariae Rhizoma prevent bone loss in vivo and in vitro.

Authors:  Shuang-Hong Song; Yuan-Kun Zhai; Cui-Qin Li; Qian Yu; Yi Lu; Yuan Zhang; Wen-Ping Hua; Zhe-Zhi Wang; Peng Shang
Journal:  Bone Rep       Date:  2016-09-10

7.  The in vitro estrogenic activity of the crude drugs found in Japanese herbal medicines prescribed for menopausal syndrome was enhanced by combining them.

Authors:  Zeyun Wang; Seiji Kanda; Takaki Shimono; Dambajamts Enkh-Undraa; Toshimasa Nishiyama
Journal:  BMC Complement Altern Med       Date:  2018-03-23       Impact factor: 3.659

8.  Hormonally active phytochemicals and vertebrate evolution.

Authors:  Max R Lambert; Thea M Edwards
Journal:  Evol Appl       Date:  2017-03-23       Impact factor: 5.183

9.  Estrogenic, Antiestrogenic and Antiproliferative Activities of Euphorbia bicolor (Euphorbiaceae) Latex Extracts and Its Phytochemicals.

Authors:  Paramita Basu; Elizabeth Meza; Michael Bergel; Camelia Maier
Journal:  Nutrients       Date:  2019-12-25       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.